Greer moves to V Foundation; Gentry named chair at UF
Gentry to chair University of Florida BMB department
Matthew Gentry, until lately a professor of molecular and cellular biochemistry at the University of Kentucky College of Medicine, has been appointed chair of the biochemistry and molecular biology department at the University of Florida College of Medicine. He will start in late August.

Gentry studies glycogen metabolism and how it goes awry in cancer and neurodegenerative disorders. Much of his early work focused on Lafora disease, a rare genetic disorder that causes progressive epilepsy beginning in adolescence. Lafora disease begins with the accumulation of insoluble polysaccharides in neurons and astrocytes. In collaboration with multiple groups and companies, Gentry’s laboratory has developed several potential therapeutic approaches for Lafora disease. He has worked with patients and their families to organize scientific meetings sponsored by a patient advocacy group called Chelsea's Hope.
Gentry earned his Ph.D. at Syracuse University and was a postdoc at the University of California San Diego with Jack Dixon before joining the University of Kentucky faculty. He is a member of the American Society for Biochemistry and Molecular Biology Council, former chair of the ASBMB's public affairs advisory committee and a member of the Journal of Biological Chemistry editorial board.
Greer joins V Foundation
Susanna Greer, until recently a senior scientific director at the American Cancer Society, has assumed a new position as the chief scientific officer at the V Foundation for Cancer Research, a North Carolina–based nonprofit. She will work with the foundation's scientific advisory committee to set funding priorities.

Greer earned her Ph.D. in microbiology and immunology at the University of Alabama at Birmingham, and was a postdoc at the University of North Carolina Chapel Hill. She spent just over 10 years as a professor studying cancer epigenetics at Georgia State University, earning tenure before she started a scientific communication consultancy and transitioned into the nonprofit world.
Greer serves on the Council and the Finance Committee of American Society for Biochemistry and Molecular Biology and was named an ASBMB fellow earlier this year. She also has served on several National Cancer Institute committees and was previously chair of the ASBMB committee on outreach and science communication.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

ASBMB names 2025 JBC/Tabor Award winners
The six awardees are first authors of outstanding papers published in 2024 in the Journal of Biological Chemistry.

Daniel N. Hebert (1962–2024)
Daniel Hebert’s colleagues remember the passionate glycobiologistscientist, caring mentor and kind friend.

In memoriam: Daniel N. Hebert
He was a professor at the University of Massachusetts Amherst, who discovered the glycan code that facilitates protein folding, maturation and quality control in the endoplasmic reticulum.

Meet Robert Helsley
The Journal of Lipid Research junior associate editor studies chronic liver disease and was the first in his family to attend college.

Exploring life’s blueprint: Gene expression in development and evolution
Meet Julia Zeitlinger and David Arnosti — two co-chairs of the ASBMB’s 2025 meeting on gene expression, to be held June 26-29, in Kansas City, Missouri.

ASBMB names 2025 fellows
American Society for Biochemistry and Molecular Biology honors 24 members for their service to the society and accomplishments in research, education, mentorship, diversity and inclusion and advocacy.